{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:36:03Z","timestamp":1790789763294,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00381-023-06037-5","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:01:41Z","timestamp":1687996901000},"page":"2675-2686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fifty years of DIPG: looking at the future with hope"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-2400","authenticated-orcid":false,"given":"Umberto","family":"Tosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Souweidane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"6037_CR1","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1200\/jco.2009.27.0421","volume":"28","author":"MA Smith","year":"2010","unstructured":"Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O\u2019Leary M, Smith FO, Reaman GH (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28:2625\u20132634. https:\/\/doi.org\/10.1200\/jco.2009.27.0421","journal-title":"J Clin Oncol"},{"key":"6037_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1541-7786.Mcr-16-0389","volume":"15","author":"FJ Cordero","year":"2017","unstructured":"Cordero FJ, Huang Z, Grenier C, He X, Hu G, McLendon RE, Murphy SK, Hashizume R, Becher OJ (2017) Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG. Mol Cancer Res 15:1243\u20131254. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-16-0389","journal-title":"Mol Cancer Res"},{"key":"6037_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, Quist MJ, Davis LE, Huang EC, Woo PJ, Ponnuswami A, Chen S, Johung TB, Sun W, Kogiso M, Du Y, Qi L, Huang Y, Hutt-Cabezas M, Warren KE, Le Dret L, Meltzer PS, Mao H, Quezado M, van Vuurden DG, Abraham J, Fouladi M, Svalina MN, Wang N, Hawkins C, Nazarian J, Alonso MM, Raabe EH, Hulleman E, Spellman PT, Li XN, Keller C, Pal R, Grill J, Monje M (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:555\u2013559. https:\/\/doi.org\/10.1038\/nm.3855","journal-title":"Nat Med"},{"key":"6037_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.critrevonc.2017.10.013","volume":"120","author":"HS Gwak","year":"2017","unstructured":"Gwak HS, Park HJ (2017) Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG). Crit Rev Oncol Hematol 120:111\u2013119. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.10.013","journal-title":"Crit Rev Oncol Hematol"},{"key":"6037_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fonc.2018.00239","volume":"8","author":"KE Warren","year":"2018","unstructured":"Warren KE (2018) Beyond the blood:brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine glioma. Front Oncol 8:239. https:\/\/doi.org\/10.3389\/fonc.2018.00239","journal-title":"Front Oncol"},{"key":"6037_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253. https:\/\/doi.org\/10.1038\/ng.1102","journal-title":"Nat Genet"},{"key":"6037_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3171\/2011.7.Peds11101","volume":"8","author":"JM Dmetrichuk","year":"2011","unstructured":"Dmetrichuk JM, Pendleton C, Jallo GI, Qui\u00f1ones-Hinojosa A (2011) Father of neurosurgery: Harvey Cushing\u2019s early experience with a pediatric brainstem glioma at the Johns Hopkins Hospital. J Neurosurg Pediatr 8:337\u2013341. https:\/\/doi.org\/10.3171\/2011.7.Peds11101","journal-title":"J Neurosurg Pediatr"},{"key":"6037_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3171\/2019.5.Peds18376","volume":"24","author":"CM Kuzan-Fischer","year":"2019","unstructured":"Kuzan-Fischer CM, Souweidane MM (2019) The intersect of neurosurgery with diffuse intrinsic pontine glioma. J Neurosurg Pediatr 24:611\u2013621. https:\/\/doi.org\/10.3171\/2019.5.Peds18376","journal-title":"J Neurosurg Pediatr"},{"key":"6037_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3171\/2015.4.Peds156","volume":"16","author":"R Rehder","year":"2015","unstructured":"Rehder R, Lohani S, Cohen AR (2015) Unsung hero: Donald Darrow Matson\u2019s legacy in pediatric neurosurgery. J Neurosurg Pediatr 16:483\u2013494. https:\/\/doi.org\/10.3171\/2015.4.Peds156","journal-title":"J Neurosurg Pediatr"},{"key":"6037_CR10","doi-asserted-by":"publisher","unstructured":"Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B, Fisher D, Kearns P, Picton S, Saran F, Gibson M, Glaser A, Connolly DJ, Hargrave D (2013) Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy - results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer (Oxford, England : 1990) 49:3856\u20133862. https:\/\/doi.org\/10.1016\/j.ejca.2013.08.006","DOI":"10.1016\/j.ejca.2013.08.006"},{"key":"6037_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","volume":"106","author":"A Chassot","year":"2012","unstructured":"Chassot A, Canale S, Varlet P, Puget S, Roujeau T, Negretti L, Dhermain F, Rialland X, Raquin MA, Grill J, Dufour C (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol 106:399\u2013407. https:\/\/doi.org\/10.1007\/s11060-011-0681-7","journal-title":"J Neurooncol"},{"key":"6037_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11060-010-0157-1","volume":"100","author":"CY Kim","year":"2010","unstructured":"Kim CY, Kim SK, Phi JH, Lee MM, Kim IA, Kim IH, Wang KC, Jung HL, Lee MJ, Cho BK (2010) A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study. J Neurooncol 100:193\u2013198. https:\/\/doi.org\/10.1007\/s11060-010-0157-1","journal-title":"J Neurooncol"},{"key":"6037_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1215\/15228517-2008-025","volume":"10","author":"N Sirachainan","year":"2008","unstructured":"Sirachainan N, Pakakasama S, Visudithbhan A, Chiamchanya S, Tuntiyatorn L, Dhanachai M, Laothamatas J, Hongeng S (2008) Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma. Neuro Oncol 10:577\u2013582. https:\/\/doi.org\/10.1215\/15228517-2008-025","journal-title":"Neuro Oncol"},{"key":"6037_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/cncr.24730","volume":"116","author":"JE Wolff","year":"2010","unstructured":"Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM (2010) Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer 116:705\u2013712. https:\/\/doi.org\/10.1002\/cncr.24730","journal-title":"Cancer"},{"key":"6037_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pbc.21154","volume":"50","author":"DN Korones","year":"2008","unstructured":"Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C (2008) Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children\u2019s Oncology Group phase II study. Pediatr Blood Cancer 50:227\u2013230. https:\/\/doi.org\/10.1002\/pbc.21154","journal-title":"Pediatr Blood Cancer"},{"key":"6037_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11060-008-9525-5","volume":"87","author":"M Massimino","year":"2008","unstructured":"Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, Giombini S, Poggi G, Pecori E, Pignoli E, Casanova M, Ferrari A, Meazza C, Luksch R, Terenziani M, Cefalo G, Podda M, Polastri D, Clerici CA, Fossati-Bellani F, Gandola L (2008) Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87:355\u2013361. https:\/\/doi.org\/10.1007\/s11060-008-9525-5","journal-title":"J Neurooncol"},{"key":"6037_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-006-9147-8","volume":"79","author":"JE Wolff","year":"2006","unstructured":"Wolff JE, Wagner S, Reinert C, Gnekow A, Kortmann RD, Kuhl J, Van Gool SW (2006) Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma. J Neurooncol 79:315\u2013321. https:\/\/doi.org\/10.1007\/s11060-006-9147-8","journal-title":"J Neurooncol"},{"key":"6037_CR18","doi-asserted-by":"publisher","unstructured":"Tosi U, Souweidane M (2020) Convection enhanced delivery for diffuse intrinsic pontine glioma: review of a single institution experience. Pharmaceutics 12. https:\/\/doi.org\/10.3390\/pharmaceutics12070660","DOI":"10.3390\/pharmaceutics12070660"},{"key":"6037_CR19","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/neuonc\/nou091","volume":"16","author":"U Bartels","year":"2014","unstructured":"Bartels U, Wolff J, Gore L, Dunkel I, Gilheeney S, Allen J, Goldman S, Yalon M, Packer RJ, Korones DN, Smith A, Cohen K, Kuttesch J, Strother D, Baruchel S, Gammon J, Kowalski M, Bouffet E (2014) Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol 16:1554\u20131559. https:\/\/doi.org\/10.1093\/neuonc\/nou091","journal-title":"Neuro Oncol"},{"key":"6037_CR20","doi-asserted-by":"publisher","unstructured":"Broniscer A, Jia S, Mandrell B, Hamideh D, Huang J, Onar-Thomas A, Gajjar A, Raimondi SC, Tatevossian RG, Stewart CF (2018) Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma. Pedia Blood Cancer 65:e27035. https:\/\/doi.org\/10.1002\/pbc.27035","DOI":"10.1002\/pbc.27035"},{"key":"6037_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/neuonc\/noq141","volume":"13","author":"B Geoerger","year":"2011","unstructured":"Geoerger B, Hargrave D, Thomas F, Ndiaye A, Frappaz D, Andreiuolo F, Varlet P, Aerts I, Riccardi R, Jaspan T, Chatelut E, Le Deley MC, Paoletti X, Saint-Rose C, Leblond P, Morland B, Gentet JC, Meresse V, Vassal G (2011) Innovative therapies for children with cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing\/refractory brain tumors. Neuro Oncol 13:109\u2013118. https:\/\/doi.org\/10.1093\/neuonc\/noq141","journal-title":"Neuro Oncol"},{"key":"6037_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-010-0141-9","volume":"100","author":"A Michalski","year":"2010","unstructured":"Michalski A, Bouffet E, Taylor RE, Hargrave D, Walker D, Picton S, Robinson K, Pizer B, Bujkiewicz S (2010) The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma. J Neurooncol 100:81\u201388. https:\/\/doi.org\/10.1007\/s11060-010-0141-9","journal-title":"J Neurooncol"},{"key":"6037_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/neuonc\/noq033","volume":"12","author":"A Narayana","year":"2010","unstructured":"Narayana A, Kunnakkat S, Chacko-Mathew J, Gardner S, Karajannis M, Raza S, Wisoff J, Weiner H, Harter D, Allen J (2010) Bevacizumab in recurrent high-grade pediatric gliomas. Neuro Oncol 12:985\u2013990. https:\/\/doi.org\/10.1093\/neuonc\/noq033","journal-title":"Neuro Oncol"},{"key":"6037_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/neuonc\/noq199","volume":"13","author":"IF Pollack","year":"2011","unstructured":"Pollack IF, Stewart CF, Kocak M, Poussaint TY, Broniscer A, Banerjee A, Douglas JG, Kun LE, Boyett JM, Geyer JR (2011) A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol 13:290\u2013297. https:\/\/doi.org\/10.1093\/neuonc\/noq199","journal-title":"Neuro Oncol"},{"key":"6037_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1227\/00006123-197805000-00006","volume":"2","author":"CA Gleason","year":"1978","unstructured":"Gleason CA, Wise BL, Feinstein B (1978) Stereotactic localization (with computerized tomographic scanning), biopsy, and radiofrequency treatment of deep brain lesions. Neurosurgery 2:217\u2013222. https:\/\/doi.org\/10.1227\/00006123-197805000-00006","journal-title":"Neurosurgery"},{"key":"6037_CR26","first-page":"198","volume":"43","author":"F Mundinger","year":"1980","unstructured":"Mundinger F, Ostertag CB, Birg W, Weigel K (1980) Stereotactic treatment of brain lesions. Biopsy, interstitial radiotherapy (iridium-192 and iodine-125) and drainage procedures. Appl Neurophysiol 43:198\u2013204","journal-title":"Appl Neurophysiol"},{"key":"6037_CR27","first-page":"275","volume":"14","author":"CB Ostertag","year":"1980","unstructured":"Ostertag CB, Mennel HD, Kiessling M (1980) Stereotactic biopsy of brain tumors. Surg Neurol 14:275\u2013283","journal-title":"Surg Neurol"},{"key":"6037_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/jns.1993.78.3.0408","volume":"78","author":"FJ Epstein","year":"1993","unstructured":"Epstein FJ, Farmer JP (1993) Brain-stem glioma growth patterns. J Neurosurg 78:408\u2013412. https:\/\/doi.org\/10.3171\/jns.1993.78.3.0408","journal-title":"J Neurosurg"},{"key":"6037_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/neuonc\/noab245","volume":"24","author":"MA Lazow","year":"2022","unstructured":"Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Garcia Lombardi M, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL (2022) Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. Neuro Oncol 24:821\u2013833. https:\/\/doi.org\/10.1093\/neuonc\/noab245","journal-title":"Neuro Oncol"},{"key":"6037_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000121010","volume":"24","author":"NJ Fischbein","year":"1996","unstructured":"Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ (1996) Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24:9\u201323. https:\/\/doi.org\/10.1159\/000121010","journal-title":"Pediatr Neurosurg"},{"key":"6037_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nou104","volume":"17","author":"MH Jansen","year":"2015","unstructured":"Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS, Reddingius R, Peeters CM, Schouten-van Meeteren AY, Gooskens RH, Granzen B, Paardekooper GM, Janssens GO, Noske DP, Barkhof F, Kramm CM, Vandertop WP, Kaspers GJ, van Vuurden DG (2015) Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 17:160\u2013166. https:\/\/doi.org\/10.1093\/neuonc\/nou104","journal-title":"Neuro Oncol"},{"key":"6037_CR32","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/neuonc\/noaa140","volume":"22","author":"JL Leach","year":"2020","unstructured":"Leach JL, Roebker J, Schafer A, Baugh J, Chaney B, Fuller C, Fouladi M, Lane A, Doughman R, Drissi R, DeWire-Schottmiller M, Ziegler DS, Minturn JE, Hansford JR, Wang SS, Monje-Deisseroth M, Fisher PG, Gottardo NG, Dholaria H, Packer R, Warren K, Leary SES, Goldman S, Bartels U, Hawkins C, Jones BV (2020) MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. Neuro Oncol 22:1647\u20131657. https:\/\/doi.org\/10.1093\/neuonc\/noaa140","journal-title":"Neuro Oncol"},{"key":"6037_CR33","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1177\/0883073816634855","volume":"31","author":"J Tisnado","year":"2016","unstructured":"Tisnado J, Young R, Peck KK, Haque S (2016) Conventional and advanced imaging of diffuse intrinsic pontine glioma. J Child Neurol 31:1386\u20131393. https:\/\/doi.org\/10.1177\/0883073816634855","journal-title":"J Child Neurol"},{"key":"6037_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s003810050542","volume":"15","author":"CR Freeman","year":"1999","unstructured":"Freeman CR, Perilongo G (1999) Chemotherapy for brain stem gliomas. Childs Nerv Syst 15:545\u2013553. https:\/\/doi.org\/10.1007\/s003810050542","journal-title":"Childs Nerv Syst"},{"key":"6037_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/pr.2013.194","volume":"75","author":"KM Schroeder","year":"2014","unstructured":"Schroeder KM, Hoeman CM, Becher OJ (2014) Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology. Pediatr Res 75:205\u2013209. https:\/\/doi.org\/10.1038\/pr.2013.194","journal-title":"Pediatr Res"},{"key":"6037_CR36","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00381-015-2832-1","volume":"31","author":"S Puget","year":"2015","unstructured":"Puget S, Beccaria K, Blauwblomme T, Roujeau T, James S, Grill J, Zerah M, Varlet P, Sainte-Rose C (2015) Biopsy in a series of 130 pediatric diffuse intrinsic pontine gliomas. Childs Nerv Syst 31:1773\u20131780. https:\/\/doi.org\/10.1007\/s00381-015-2832-1","journal-title":"Childs Nerv Syst"},{"key":"6037_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2017.2.Peds1665","volume":"20","author":"C Hamisch","year":"2017","unstructured":"Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI (2017) Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 20:261\u2013268. https:\/\/doi.org\/10.3171\/2017.2.Peds1665","journal-title":"J Neurosurg Pediatr"},{"key":"6037_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, Pag\u00e8s M, Taylor KR, Saulnier P, Lacroix L, Mackay A, Jones C, Sainte-Rose C, Blauwblomme T, Andreiuolo F, Puget S, Grill J, Varlet P, Debily MA (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815\u2013827. https:\/\/doi.org\/10.1007\/s00401-015-1478-0","journal-title":"Acta Neuropathol"},{"key":"6037_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/nan.12432","volume":"44","author":"P Wesseling","year":"2018","unstructured":"Wesseling P, Capper D (2018) WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol 44:139\u2013150. https:\/\/doi.org\/10.1111\/nan.12432","journal-title":"Neuropathol Appl Neurobiol"},{"key":"6037_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/neuonc\/now101","volume":"19","author":"C Jones","year":"2017","unstructured":"Jones C, Karajannis MA, Jones DTW, Kieran MW, Monje M, Baker SJ, Becher OJ, Cho YJ, Gupta N, Hawkins C, Hargrave D, Haas-Kogan DA, Jabado N, Li XN, Mueller S, Nicolaides T, Packer RJ, Persson AI, Phillips JJ, Simonds EF, Stafford JM, Tang Y, Pfister SM, Weiss WA (2017) Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol 19:153\u2013161. https:\/\/doi.org\/10.1093\/neuonc\/now101","journal-title":"Neuro Oncol"},{"key":"6037_CR41","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Sunol M, de Torres C, Cruz O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A, Jones C (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32:520-537.e525. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"key":"6037_CR42","doi-asserted-by":"publisher","unstructured":"Lin GL, Wilson KM, Ceribelli M, Stanton BZ, Woo PJ, Kreimer S, Qin EY, Zhang X, Lennon J, Nagaraja S, Morris PJ, Quezada M, Gillespie SM, Duveau DY, Michalowski AM, Shinn P, Guha R, Ferrer M, Klumpp-Thomas C, Michael S, McKnight C, Minhas P, Itkin Z, Raabe EH, Chen L, Ghanem R, Geraghty AC, Ni L, Andreasson KI, Vitanza NA, Warren KE, Thomas CJ, Monje M (2019) Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med 11. https:\/\/doi.org\/10.1126\/scitranslmed.aaw0064","DOI":"10.1126\/scitranslmed.aaw0064"},{"key":"6037_CR43","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja S, Vitanza NA, Woo PJ, Taylor KR, Liu F, Zhang L, Li M, Meng W, Ponnuswami A, Sun W, Ma J, Hulleman E, Swigut T, Wysocka J, Tang Y, Monje M (2017) Transcriptional dependencies in diffuse intrinsic pontine glioma. Cancer Cell 31:635-652.e636. https:\/\/doi.org\/10.1016\/j.ccell.2017.03.011","journal-title":"Cancer Cell"},{"key":"6037_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fonc.2017.00254","volume":"7","author":"FE El-Khouly","year":"2017","unstructured":"El-Khouly FE, van Vuurden DG, Stroink T, Hulleman E, Kaspers GJL, Hendrikse NH, Veldhuijzen van Zanten SEM (2017) Effective drug delivery in diffuse intrinsic pontine glioma: a theoretical model to identify potential candidates. Front Oncol 7:254. https:\/\/doi.org\/10.3389\/fonc.2017.00254","journal-title":"Front Oncol"},{"key":"6037_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11060-015-1969-9","volume":"126","author":"E Subashi","year":"2016","unstructured":"Subashi E, Cordero FJ, Halvorson KG, Qi Y, Nouls JC, Becher OJ, Johnson GA (2016) Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma. J Neurooncol 126:243\u2013251. https:\/\/doi.org\/10.1007\/s11060-015-1969-9","journal-title":"J Neurooncol"},{"key":"6037_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol 2:205. https:\/\/doi.org\/10.3389\/fonc.2012.00205","journal-title":"Front Oncol"},{"key":"6037_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tranon.2019.11.006","volume":"13","author":"UB Maachani","year":"2020","unstructured":"Maachani UB, Tosi U, Pisapia DJ, Mukherjee S, Marnell CS, Voronina J, Martinez D, Santi M, Dahmane N, Zhou Z, Hawkins C, Souweidane MM (2020) B7\u2013H3 as a prognostic biomarker and therapeutic target in pediatric central nervous system tumors. Transl Oncol 13:365\u2013371. https:\/\/doi.org\/10.1016\/j.tranon.2019.11.006","journal-title":"Transl Oncol"},{"key":"6037_CR48","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/s1470-2045(18)30322-x","volume":"19","author":"MM Souweidane","year":"2018","unstructured":"Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, Turner RS, Lewis JS, Cheung NV, Larson SM, Dunkel IJ (2018) Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. Lancet Oncol 19:1040\u20131050. https:\/\/doi.org\/10.1016\/s1470-2045(18)30322-x","journal-title":"Lancet Oncol"},{"key":"6037_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jneumeth.2015.11.008","volume":"259","author":"O Lewis","year":"2016","unstructured":"Lewis O, Woolley M, Johnson D, Rosser A, Barua NU, Bienemann AS, Gill SS, Evans S (2016) Chronic, intermittent convection-enhanced delivery devices. J Neurosci Methods 259:47\u201356. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.11.008","journal-title":"J Neurosci Methods"},{"key":"6037_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3171\/2020.2.Peds19786","volume":"26","author":"DI Sandberg","year":"2020","unstructured":"Sandberg DI, Kharas N, Yu B, Janssen CF, Trimble A, Ballester LY, Patel R, Mohammad AS, Elmquist WF, Sirianni RW (2020) High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model. J Neurosurg Pediatr 26:127\u2013135. https:\/\/doi.org\/10.3171\/2020.2.Peds19786","journal-title":"J Neurosurg Pediatr"},{"key":"6037_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3171\/2018.2.Peds17663","volume":"22","author":"WGB Singleton","year":"2018","unstructured":"Singleton WGB, Bienemann AS, Woolley M, Johnson D, Lewis O, Wyatt MJ, Damment SJP, Boulter LJ, Killick-Cole CL, Asby DJ, Gill SS (2018) The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery. J Neurosurg Pediatr 22:288\u2013296. https:\/\/doi.org\/10.3171\/2018.2.Peds17663","journal-title":"J Neurosurg Pediatr"},{"key":"6037_CR52","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/s1470-2045(22)00599-x","volume":"23","author":"EF Spinazzi","year":"2022","unstructured":"Spinazzi EF, Argenziano MG, Upadhyayula PS, Banu MA, Neira JA, Higgins DMO, Wu PB, Pereira B, Mahajan A, Humala N, Al-Dalahmah O, Zhao W, Save AV, Gill BJA, Boyett DM, Marie T, Furnari JL, Sudhakar TD, Stopka SA, Regan MS, Catania V, Good L, Zacharoulis S, Behl M, Petridis P, Jambawalikar S, Mintz A, Lignelli A, Agar NYR, Sims PA, Welch MR, Lassman AB, Iwamoto FM, D\u2019Amico RS, Grinband J, Canoll P, Bruce JN (2022) Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial. Lancet Oncol 23:1409\u20131418. https:\/\/doi.org\/10.1016\/s1470-2045(22)00599-x","journal-title":"Lancet Oncol"},{"key":"6037_CR53","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10147-020-01853-0","volume":"26","author":"E Szychot","year":"2021","unstructured":"Szychot E, Walker D, Collins P, Hyare H, Shankar A, Bienemann A, Hollingworth M, Gill S (2021) Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy. Int J Clin Oncol 26:647\u2013658. https:\/\/doi.org\/10.1007\/s10147-020-01853-0","journal-title":"Int J Clin Oncol"},{"key":"6037_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/nop\/npab065","volume":"9","author":"JH Kang","year":"2022","unstructured":"Kang JH, Desjardins A (2022) Convection-enhanced delivery for high-grade glioma. Neurooncol Pract 9:24\u201334. https:\/\/doi.org\/10.1093\/nop\/npab065","journal-title":"Neurooncol Pract"},{"key":"6037_CR55","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1158\/1078-0432.Ccr-21-3324","volume":"28","author":"EHP van Putten","year":"2022","unstructured":"van Putten EHP, Kleijn A, van Beusechem VW, Noske D, Lamers CHJ, de Goede AL, Idema S, Hoefnagel D, Kloezeman JJ, Fueyo J, Lang FF, Teunissen CE, Vernhout RM, Bakker C, Gerritsen W, Curiel DT, Vulto A, Lamfers MLM, Dirven CMF (2022) Convection enhanced delivery of the oncolytic adenovirus Delta24-RGD in patients with recurrent GBM: a phase I clinical trial including correlative studies. Clin Cancer Res 28:1572\u20131585. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-3324","journal-title":"Clin Cancer Res"},{"key":"6037_CR56","doi-asserted-by":"publisher","unstructured":"Vogelbaum MA, Sampson JH, Kunwar S, Chang SM, Shaffrey M, Asher AL, Lang FF, Croteau D, Parker K, Grahn AY, Sherman JW, Husain SR, Puri RK (2007) Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery 61:1031\u20131037; discussion 1037\u20131038. https:\/\/doi.org\/10.1227\/01.neu.0000303199.77370.9e","DOI":"10.1227\/01.neu.0000303199.77370.9e"},{"key":"6037_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bpa.12082","volume":"24","author":"NU Barua","year":"2014","unstructured":"Barua NU, Gill SS, Love S (2014) Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations. Brain Pathol 24:117\u2013127. https:\/\/doi.org\/10.1111\/bpa.12082","journal-title":"Brain Pathol"},{"key":"6037_CR58","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/neuonc\/nop054","volume":"12","author":"S Kunwar","year":"2010","unstructured":"Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK (2010) Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 12:871\u2013881. https:\/\/doi.org\/10.1093\/neuonc\/nop054","journal-title":"Neuro Oncol"},{"key":"6037_CR59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3171\/2009.11.Jns091052","volume":"113","author":"JH Sampson","year":"2010","unstructured":"Sampson JH, Archer G, Pedain C, Wembacher-Schroder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodriguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK (2010) Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113:301\u2013309. https:\/\/doi.org\/10.3171\/2009.11.Jns091052","journal-title":"J Neurosurg"},{"key":"6037_CR60","doi-asserted-by":"publisher","unstructured":"Chang R, Tosi U, Voronina J, Adeuyan O, Wu LY, Schweitzer ME, Pisapia DJ, Becher OJ, Souweidane MM, Maachani UB (2019) Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy. Neurooncol Adv 1:vdz004. https:\/\/doi.org\/10.1093\/noajnl\/vdz004","DOI":"10.1093\/noajnl\/vdz004"},{"key":"6037_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1021\/acsmedchemlett.7b00471","volume":"9","author":"H Kommidi","year":"2018","unstructured":"Kommidi H, Tosi U, Maachani UB, Guo H, Marnell CS, Law B, Souweidane MM, Ting R (2018) (18)F-Radiolabeled panobinostat allows for positron emission tomography guided delivery of a histone deacetylase inhibitor. ACS Med Chem Lett 9:114\u2013119. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00471","journal-title":"ACS Med Chem Lett"},{"key":"6037_CR62","doi-asserted-by":"publisher","unstructured":"Tosi U, Kommidi H, Adeuyan O, Guo H, Maachani UB, Chen N, Su T, Zhang G, Pisapia DJ, Dahmane N, Ting R, Souweidane MM (2020) PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models. Sci Adv 6:eabb4105. https:\/\/doi.org\/10.1126\/sciadv.abb4105","DOI":"10.1126\/sciadv.abb4105"},{"key":"6037_CR63","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1021\/acschemneuro.8b00607","volume":"10","author":"U Tosi","year":"2019","unstructured":"Tosi U, Kommidi H, Bellat V, Marnell CS, Guo H, Adeuyan O, Schweitzer ME, Chen N, Su T, Zhang G, Maachani UB, Pisapia DJ, Law B, Souweidane MM, Ting R (2019) Real-time, in vivo correlation of molecular structure with drug distribution in the brain striatum following convection enhanced delivery. ACS Chem Neurosci 10:2287\u20132298. https:\/\/doi.org\/10.1021\/acschemneuro.8b00607","journal-title":"ACS Chem Neurosci"},{"key":"6037_CR64","doi-asserted-by":"publisher","unstructured":"Tosi U, Marnell CS, Chang R, Cho WC, Ting R, Maachani UB, Souweidane MM (2017) Advances in molecular imaging of locally delivered targeted therapeutics for central nervous system tumors. Int J Mol Sci 18. https:\/\/doi.org\/10.3390\/ijms18020351","DOI":"10.3390\/ijms18020351"},{"key":"6037_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.wneu.2020.01.199","volume":"137","author":"U Tosi","year":"2020","unstructured":"Tosi U, Souweidane MM (2020) Longitudinal monitoring of Gd-DTPA following convection enhanced delivery in the brainstem. World Neurosurg 137:38\u201342. https:\/\/doi.org\/10.1016\/j.wneu.2020.01.199","journal-title":"World Neurosurg"},{"key":"6037_CR66","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1158\/1535-7163.Mct-17-0423","volume":"16","author":"M Wang","year":"2017","unstructured":"Wang M, Kommidi H, Tosi U, Guo H, Zhou Z, Schweitzer ME, Wu LY, Singh R, Hou S, Law B, Ting R, Souweidane MM (2017) A murine model for quantitative, real-time evaluation of convection-enhanced delivery (RT-CED) using an (18)[F]-positron emitting, fluorescent derivative of dasatinib. Mol Cancer Ther 16:2902\u20132912. https:\/\/doi.org\/10.1158\/1535-7163.Mct-17-0423","journal-title":"Mol Cancer Ther"},{"key":"6037_CR67","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/jco.2017.75.8219","volume":"36","author":"FF Lang","year":"2018","unstructured":"Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, Prabhu SS, Rao G, Fuller GN, Aldape KD, Gumin J, Vence LM, Wistuba I, Rodriguez-Canales J, Villalobos PA, Dirven CMF, Tejada S, Valle RD, Alonso MM, Ewald B, Peterkin JJ, Tufaro F, Fueyo J (2018) Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma. J Clin Oncol 36:1419\u20131427. https:\/\/doi.org\/10.1200\/jco.2017.75.8219","journal-title":"J Clin Oncol"},{"key":"6037_CR68","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","volume":"386","author":"J G\u00e1llego P\u00e9rez-Larraya","year":"2022","unstructured":"G\u00e1llego P\u00e9rez-Larraya J, Garcia-Moure M, Labiano S, Pati\u00f1o-Garc\u00eda A, Dobbs J, Gonzalez-Huarriz M, Zalacain M, Marrodan L, Martinez-Velez N, Puigdelloses M, Laspidea V, Astigarraga I, Lopez-Ibor B, Cruz O, Oscoz Lizarbe M, Hervas-Stubbs S, Alkorta-Aranburu G, Tamayo I, Tavira B, Hernandez-Alcoceba R, Jones C, Dharmadhikari G, Ruiz-Moreno C, Stunnenberg H, Hulleman E, van der Lugt J, Idoate M, Diez-Valle R, Esparragosa V\u00e1zquez I, Villalba M, de Andrea C, N\u00fa\u00f1ez-C\u00f3rdoba JM, Ewald B, Robbins J, Fueyo J, Gomez-Manzano C, Lang FF, Tejada S, Alonso MM (2022) Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med 386:2471\u20132481. https:\/\/doi.org\/10.1056\/NEJMoa2202028","journal-title":"N Engl J Med"},{"key":"6037_CR69","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"RG Majzner","year":"2022","unstructured":"Majzner RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM, Richards RM, Jiang L, Barsan V, Mancusi R, Geraghty AC, Good Z, Mochizuki AY, Gillespie SM, Toland AMS, Mahdi J, Reschke A, Nie EH, Chau IJ, Rotiroti MC, Mount CW, Baggott C, Mavroukakis S, Egeler E, Moon J, Erickson C, Green S, Kunicki M, Fujimoto M, Ehlinger Z, Reynolds W, Kurra S, Warren KE, Prabhu S, Vogel H, Rasmussen L, Cornell TT, Partap S, Fisher PG, Campen CJ, Filbin MG, Grant G, Sahaf B, Davis KL, Feldman SA, Mackall CL, Monje M (2022) GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 603:934\u2013941. https:\/\/doi.org\/10.1038\/s41586-022-04489-4","journal-title":"Nature"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-023-06037-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-023-06037-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-023-06037-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T02:04:34Z","timestamp":1698458674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-023-06037-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6037"],"URL":"https:\/\/doi.org\/10.1007\/s00381-023-06037-5","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interest, financial or otherwise, to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}